ArticleThe Journal of experimental medicine1999

Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies.

T L O'Keefe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.